Afuco™ Anti-Human DLK1 ADCC Therapeutic Antibody (LIV-1205), ADCC Enhanced
Anti-DLK1 ADCC Enhanced Antibody (LIV-1205) is an ADCC enhanced antibody produced by our Afuco™ platform. LIV-1205 is a humanized monoclonal antibody targeting cell surface antigen "DLK-1 (Delta-like 1 homolog)" of liver cancer and other solid cancers. DLK-1 is expected to control the proliferation and differentiation of stem cells, progenitor cells, and other immature cells. LIV-1205 have shown potent anti-tumor activity in various cancer models and is expected to have beneficial clinical efficacy.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-203CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | DLK1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |